Loading
Latest filing published 14 Oct 2026 for 페니트리움바이오. Read the official filing
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of 현대바이오 across 2 companies, led by 페니트리움바이오 and 현대바이오. The record holds 22 filings, for trades running from 11 March 2024 to 14 October 2026.
No open-market sale appears; the market trades are 8 purchases. The amount is not disclosed for 8 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2026 alone, the filings show 1 purchase and no sales.
None of the 5 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The record was last updated on 14 October 2026 with a transaction in 페니트리움바이오. The latest purchase dates back some time: it was published 44 days ago, on 4 September 2026. Between a trade and the moment it shows up on DART (FSS), the median delay is 7 days. This delay matters because a trade only becomes useful information once it is public. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations